Investors

INMODE INVESTOR PORTAL

CORPORATE OVERVIEW


InMode Ltd. (Nasdaq: INMD) is a leading global provider of innovative medical technologies. InMode develops, manufacturers, and markets devices harnessing novel radio-frequency (RF) based devices that strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology and ophthalmology.

COMPANY HIGHLIGHTS

STOCK PERFORMANCE

NASDAQ : INMD

PRICE

$0

CHANGE

0(0%)

VOLUME

0

Copyright Nasdaq. Latest trading day: .

Press Releases

InMode to Report Third Quarter 2026 Financial Results on November 11, 2026, Expects Third Quarter Revenue of $91.8 Million to $92.0 Million

InMode Advances RF Microneedling Comfort with the Launch of Morpheus8 Cool

InMode Reports Second Quarter 2026 Financial Results: Quarterly GAAP Revenues of $95.6 Million, Consistent with the Second Quarter of 2025

Financials & Filings

SEC FILINGS

Contact Us

Contact Us